Back to Journals » Clinical Ophthalmology » Volume 14

Astigmatic Results of a Diffractive Trifocal Toric IOL Following Intraoperative Aberrometry Guidance

Authors Blaylock JF, Hall B

Received 19 October 2020

Accepted for publication 23 November 2020

Published 14 December 2020 Volume 2020:14 Pages 4373—4378


Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 4

Editor who approved publication: Dr Scott Fraser

John F Blaylock,1 Brad Hall2

1Valley Laser Eye Centre, Abbotsford, BC, Canada; 2Sengi, Penniac, NB, Canada

Correspondence: Brad Hall
Sengi, 473 Route 628, Penniac, NB E3A 8X8, Canada
Tel +1 888-255-8680

Purpose: To determine if intraoperative aberrometry (IA) improves astigmatic outcomes for trifocal toric IOL (TTI) cases.
Patients and Methods: This was a retrospective study examining 137 eyes that underwent cataract extraction and TTI implantation using femtosecond laser, digital registration, and IA. Final cylinder power and axis of placement were determined by IA. Monocular uncorrected distance visual acuity (UDVA), uncorrected intermediate visual acuity (UIVA), uncorrected near visual acuity (UNVA), and refractive data were collected at 3 months. Postoperative residual astigmatism (PRA) determined by manifest refraction was compared to back-calculated residual astigmatism (BRA) using the cylinder power calculated preoperatively.
Results: Postoperatively, 97.8% of eyes had IA PRA ≤ 0.50D and 80.3% had BRA ≤ 0.50 D, a difference of 17.5%. Mean PRA for IA was 0.07 D ± 0.19 (range 0.00– 1.00 D) compared to BRA 0.31 D ± 0.33 (range 0.00– 1.34 D) (P < 0.001). Cylinder power was changed in 50.4% of cases based upon IA. Postoperative mean UDVA (LogMAR) was 0.04 ± 0.09 (range − 0.12– 0.30 logMAR), and 65% of eyes were ≤ 0.0, 85% ≤ 0.1, and 99% ≤ 0.18.
Conclusion: The proportion of eyes with PRA ≤ 0.50 D and mean PRA was significantly lower using IA versus the preoperative planned cylinder power.

Keywords: PanOptix, trifocal IOL, toric IOL, cataract surgery

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]